Mark<p>Mission to revive a forgotten, life-saving <a href="https://mastodon.scot/tags/cancer" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>cancer</span></a> drug</p><p><a href="https://mastodon.scot/tags/Aclarubicin" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Aclarubicin</span></a>, unavailable in Europe for 20 years, could have helped 100k with blood cancer</p><p>“There’s no patent on this compound, so industry isn’t interested.” says <a href="https://mastodon.scot/tags/Neefjes" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Neefjes</span></a></p><p>Since the patent expired, there's no incentive for <a href="https://mastodon.scot/tags/BigPharma" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>BigPharma</span></a> to invest in it, since competitors are free to produce the drug</p><p>That leaves small grants, charity & independent funding – and for Neefjes</p><p><a href="https://www.theguardian.com/science/article/2024/jul/27/one-mans-mission-to-revive-a-forgotten-life-saving-cancer-drug" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">theguardian.com/science/articl</span><span class="invisible">e/2024/jul/27/one-mans-mission-to-revive-a-forgotten-life-saving-cancer-drug</span></a></p><p><a href="https://mastodon.scot/tags/CapitalismFails" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>CapitalismFails</span></a> <a href="https://mastodon.scot/tags/BigPharma" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>BigPharma</span></a></p>